Association of mutation profiles with metastasis in patients with non-small cell lung cancer
Patients with ALK mutant, BRAF mutant or NRAS mutant were more prone to metastasis, while the HER 2 mutation group was less metastatic. Patients with EGFR mutant NSCLC are more likely to develop bone, lung, or brain metastasis.
Authors
- Yingxue Li (ORCID: https://orcid.org/0000-0002-3605-2975)
- Lin Han (ORCID: https://orcid.org/0000-0002-7398-0199)
- Xia Liu (ORCID: https://orcid.org/0000-0002-9987-3332)
- Ying Du (ORCID: https://orcid.org/0000-0001-6767-0402)
- Li Wang (ORCID: https://orcid.org/0000-0002-5315-0593)
- Zheng Zheng (ORCID: https://orcid.org/0000-0003-0421-9272)
- Jiaping Xie
- Xuedong Zhang (ORCID: https://orcid.org/0000-0002-9224-0698)
Institutions
- Shandong University (CN)
- Liaocheng University (CN)
- Liaocheng People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.3389/fonc.2024.1451576
- Citations
- 6
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 2.51